Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Featured News

    Brain Discovery Could Lead to New Treatments for the Flu

    By Global Biodefense StaffJanuary 12, 2015
    Antivirals for Influenza Respiratory Infection
    Credit: Shutterstock
    Share
    Facebook LinkedIn Reddit Email

    Washington State University Spokane scientists have found a brain protein that boosts the healing power of sleep and speeds an animal’s recovery from the flu.

    Research by WSU Regents Professor James M. Krueger has determined that a brain-specific protein is uniquely involved in sleep responses triggered by the influenza virus in mice. Without the protein, animals develop more severe symptoms of infection and die at higher rates than regular or control mice.

    Krueger said the discovery could lead to alternative treatments for influenza and other infectious diseases, possibly by using intranasal sprays to stimulate the production of the brain protein, called AcPb.

    Previous research indicates that sleep is necessary for a healthy immune system and plays a critical role in the body’s response to bacterial and viral infections.

    Krueger showed this recovery involves AcPb and an immune system signaling chemical called interleukin-1. AcPb links up with interleukin-1 to help regulate sleep in healthy animals. It also prompts infected animals to spend more time sleeping during an illness.

    In the study, mice who lacked the gene for AcPb slept less after being infected with influenza virus. They also became chilled, grew sluggish, lost their normal circadian rhythms and ultimately died in higher numbers than the mice who slept longer.

    Krueger’s findings were reported in the journal Brain, Behavior, and Immunity in November.

    H1N1 Influenza

    For the study, Krueger and his colleagues gave an intranasal dose of mouse-adapted H1N1 influenza virus to both regular mice and those lacking the gene for AcPb. H1N1 is the strain of influenza that swept across the world in the 2009 pandemic.

    When infected, regular mice showed the typical prolonged sleep response, but mice lacking AcPb slept less than control mice. They also developed more severe symptoms of illness and died at a higher rate.

    A Neurological Perspective

    “Influenza is a lung disease,” said Krueger, “and deaths probably occur from fluid building up in the lungs. But now, we see that without AcPb in the brain, the virus is even more deadly. Why would the brain be regulating a lung disease?”

    “We knew that the virus replicated in the lungs,” he said, “but we’ve discovered it also reaches parts of the brain – causing an inflammatory reaction involving interleukin-1 and AcPb. That reaction induces the increased sleep response that helps the body overcome an infection.

    Interleukin-1 is also one of the inflammatory molecules responsible for the freezing, aching, feverish misery of the flu.

    “This finding expands our knowledge of the molecular pathway involved in recovery from influenza,” said Krueger, who hopes virologists will take note.

    New Flu Treatments Possible

    Speculating on possible new treatments for the flu, Krueger explained that the interleukin-1 – AcPb signaling complex is linked to a different molecule in the immune system called growth hormone releasing hormone (GHRH) and its receptor (GHRHR.)

    He said GHRHR was “previously shown to be critical to the healing sleep responses induced by the influenza virus, so this may offer another potential clinical approach to treat influenza and other microbial diseases.”

    Krueger said that while GHRH has not yet been used for treating infectious disease, other scientists are experimenting with it as a possible aid for memory and sleep.

    A 2012 study by Laura Baker, a memory researcher at the University of Washington & VA Puget Sound Health Care System in Seattle showed that daily injections of GHRH boosted the mental agility of older people with and without mild cognitive decline.

    And in 2009, German scientists developed an intranasal spray using interleukin-6 that was said to help the brain retain emotional and procedural memories during REM sleep.

    Antivirals Influenza
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – January 11, 2015
    Next Article PNNL Biodetection Guide Downloaded By 10,000+

    Related Stories

    Human BCG Challenge Model for Assessment of Tuberculosis Immunity

    December 2, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Black Death Impact on Microbiome May Have Contributed to Modern-Day Chronic Diseases

    November 29, 2023

    NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

    November 14, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Dec 5
    10:45 am - 3:00 pm EST

    Meeting the Moment: Biodefense Policy, Procurement, and Public Health

    Dec 6
    Virtual Event Virtual Event
    6:00 am - 7:00 am EST

    AMR One Health Priority Research Agenda: Transmission

    Mar 12
    Virtual Event Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.